Aquestive Therapeutics (AQST) Accumulated Expenses (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Accumulated Expenses of $3.4 million for Q1 2026, up 4.07% year-over-year from $3.3 million in Q1 2025, and down 31.42% quarter-over-quarter from $5.0 million in Q4 2025.
Aquestive Therapeutics (AQST) Accumulated Expenses (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Accumulated Expenses history runs 10 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 4.07% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 4.07% YoY), while the FY2025 annual figure was $5.0 million, down 14.86% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $3.4 million, down from $5.0 million in the prior quarter.
- The five-year high for Accumulated Expenses was $8.0 million in Q4 2022, with the low at $3.3 million in Q1 2025.
- The 5-year median for Accumulated Expenses is $5.0 million (2025), against an average of $5.4 million.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses plunged 39.46% in 2023, then soared 33.1% in 2024.
- Aquestive Therapeutics' Accumulated Expenses stood at $8.0 million in 2022, then fell by 18.45% to $6.5 million in 2023, then fell by 9.08% to $5.9 million in 2024, then fell by 14.86% to $5.0 million in 2025, then sank by 31.42% to $3.4 million in 2026.
- Business Quant data shows AQST's Accumulated Expenses at $3.4 million in Q1 2026, $5.0 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Aquestive Therapeutics | 554.35 Mn | 554.35 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.52 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 5.03 Mn |
| Sep 30, 2025 | 5.13 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 5.67 Mn |
| Mar 31, 2024 | 4.64 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 5.47 Mn |
| Jun 30, 2023 | 4.26 Mn |
| Mar 31, 2023 | 4.51 Mn |
| Dec 31, 2022 | 7.97 Mn |
| Sep 30, 2022 | 7.73 Mn |
| Jun 30, 2022 | 7.04 Mn |
| Mar 31, 2022 | 4.87 Mn |
| Dec 31, 2021 | 8.74 Mn |
| Sep 30, 2021 | 7.62 Mn |